News
Syndax Presents Positive Revuforj ® (revumenib) Data in Acute Leukemias from Multiple Trials, Including the SAVE Combination and AUGMENT-101 Trials, at 66th ASH Annual Meeting
By: investing_ng
- Dec 08 2024
- 0
- 0 Views
Share this page
Guest Posts by Easy Branches Data in Acute Leukemias from Multiple Trials, Including the SAVE Combination and AUGMENT-101 Trials, at 66th ASH Annual Meeting&url=https://easybranches.com/feed/ng/news/10661598&media=https://easybranches.com/feed/uploads/2024/12/4f55382d33a6590a5d1160832c84506b.jpg){kind=link}
